GUADALUPE LEMUS: Open Payments
NPI 1962803692 · PORTERVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 58 payments from 13 companies in 2025. Trend: 2023 $1,589 · 2024 $2,318 · 2025 $1,376
Food & beverage: $1,338Education: $38
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $344 |
| ABBVIE INC. | 10 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $172 |
| Lilly USA, LLC | 5 | $163 |
| Novo Nordisk Inc | 12 | $155 |
| Philips North America LLC | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
Products named: BREZTRI, JARDIANCE, CAPLYTA, VRAYLAR, Wegovy, Vest Therapy Und, QULIPTA, REXULTI.
Industry payments across CA — which companies pay providers there.
